Showing results (41-50 of 76) with videos related to
Sort By:
Pageof 8
Frontiers in Immunology|December 16, 2021
Transcriptomic and Single-Cell Analysis Reveals Regulatory Networks and Cellular Heterogeneity in Mouse Primary Sjögren's Syndrome Salivary GlandsErich Horeth, Akinsola Oyelakin, Eun-Ah Christine Song, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 13, 2025
In Vivo PET Imaging of [<sup>18</sup>F]CHDI-385, a Radioligand for Mutant Huntingtin Aggregates in a Mouse Model of Huntington DiseaseFranziska Zajicek, Filipe Elvas, Alan Miranda, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 17, 2021
Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease PostmortemDaniele Bertoglio, Jeroen Verhaeghe, Leonie Wyffels, et al.Plos One|April 30, 2015
Global Developmental Gene Programing Involves a Nuclear Form of Fibroblast Growth Factor Receptor-1 (FGFR1)Christopher Terranova, Sridhar T Narla, Yu-Wei Lee, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 16, 2022
Validation, kinetic modeling, and test-retest reproducibility of [<sup>18</sup>F]SynVesT-1 for PET imaging of synaptic vesicle glycoprotein 2A in miceDaniele Bertoglio, Franziska Zajicek, Stef De Lombaerde, et al.Database : the Journal of Biological Databases and Curation|July 15, 2010
Mouse Resource Browser--a database of mouse databasesMichael Zouberakis, Christina Chandras, Morris Swertz, et al.European Journal of Nuclear Medicine and Molecular Imaging|August 27, 2024
Preclinical evaluation of the novel [<sup>18</sup>F]CHDI-650 PET ligand for non-invasive quantification of mutant huntingtin aggregates in Huntington's diseaseFranziska Zajicek, Jeroen Verhaeghe, Stef De Lombaerde, et al.European Journal of Nuclear Medicine and Molecular Imaging|October 15, 2021
Longitudinal preclinical evaluation of the novel radioligand [11C]CHDI-626 for PET imaging of mutant huntingtin aggregates in Huntington's diseaseDaniele Bertoglio, Jeroen Verhaeghe, Alan Miranda, et al.Journal of Molecular Medicine (Berlin, Germany)|December 18, 2025
Preclinical evaluation of [<sup>11</sup>C]CHDI-009R for quantification of mutant huntingtin aggregatesFranziska Zajicek, Liesbeth Everix, Annemie Van Eetveldt, et al.Bioorganic & Medicinal Chemistry Letters|September 1, 2007
Thiophene substituted acylguanidines as BACE1 inhibitorsWilliam F Fobare, William R Solvibile, Albert J Robichaud, et al.Pageof 8